However, according to our current research results, it is difficult to infer the role of IL-10 and IL-17 because although the increase in IL-10 and IL-17 production was accompanied by the activation of antitumour immunity and the inhibition of tumour growth, a large number of other immunostimulatory cytokines were also increased. The gene discussed is IL17A; the disease is neoplasm.